Dr. Robert Platt appointed Interim Chair, Department of Epidemiology, Biostatistics and Occupational Health

We are pleased to announce the appointment of Dr. Robert Platt as Interim Chair, Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, Faculty of Medicine, McGill University. Please join us in thanking Dr. Platt for taking on this position and in wishing him every success in this role.
Read more ►

 

Dr. Charles Larson appointed Interim Director, Global Health Programs

We are delighted to announce the appointment of Dr. Charles Larson to the position of Interim Director, Global Health Programs (GHP), School of Population and Global Health (SPGH), Faculty of Medicine, McGill University. In his role as Interim Director, Dr. Larson will be accountable for the oversight of all activities under the umbrella of McGill Global Health Programs as well as overseeing the strategic vision in the creation of a new division under the SPGH. Please join us in congratulating Dr. Larson as he embarks on this new leadership role.
Read more ►

 

Dr. Armen Aprikian appointed Clinical Lead, Rossy Cancer Network

We are pleased to announce the appointment of Dr. Armen Aprikian as the Clinical Lead for the Rossy Cancer Network.  Please join us in welcoming Dr. Aprikian to this new role and in wishing him success as he continues to build on the Rossy Cancer Network’s objective to improve the quality of cancer care for patients across our community.
Read more ►

 

Read More Posts From This Section »

McGill to take “significant steps” to increase the resumption of all types of activities on campus

On Monday, Fabrice Labeau, Deputy Provost (Student Life and Learning), updated the McGill community on how the University will “take significant steps” in coming weeks to “to increase the resumption of all types of activities across our campuses.”
Read more ►

 

Coronavirus (COVID-19) update – July 27, 2020

Message from Fabrice Labeau, Deputy Provost

As Provost Manfredi and Vice-Principal Beauchamp wrote to you last week, our society is now living in a period of learning to co-exist with COVID-19. The success of our ongoing, multi-phase research ramp-up is proof positive that, together, well-considered institutional directives and conscientious individual efforts can result in safely re-opening our physical spaces. We will now take significant steps in the weeks to come to increase the resumption of all types of activities across our campuses.
Read more ►

 

Pursuing the gradual return to campus

From its very beginning in March, the goal of the COVID-19 lockdown was to “flatten the curve” in order to lessen the strain on critical health care services. Throughout this period, the University has been proactive in developing plans to prioritize the health and safety of the community, as well as to ensure the successful continuity of our academic mission.
Read more ►

 

Read More Posts From This Section »

MIMM Bites Newsletter – June 2020

We are pleased to announce that the June issue is now available online. It provides news and announcements of interest to the faculty and support staff members, as well as to students and alumni members. It also presents information on department updates, upcoming events and announcements.
Read more ►

 

Read More Posts From This Section »

In Memoriam: Dr. Harvey Barkun (1928-2020)

It is with great sadness that we share the news of the passing of Dr. Harvey Barkun on Friday, July 17, 2020, at the age of 92 years. Born and raised in Montreal, Dr. Barkun was successively appointed medical director at St-Anne’s Hospital, the Queen Mary Veteran’s Hospital, and the Royal Victoria Hospital before being named chief executive officer of the Montreal General Hospital (1972-l1988). He also served as Associate Dean, Professional Affairs in the Faculty of Medicine at McGill University (1975-1997).

Dr. Barkun was a talented, passionate and righteous born leader with a wicked, dry sense of humour and an incredibly sharp mind until his passing, writes Dr. Alain Bitton. He leaves us, having impacted so powerfully through his generosity, compassion and open-mindedness on so many colleagues including his surviving family who will miss him dearly. Our condolences go out to Dr. Barkun’s family, friends, colleagues and all those whose lives he touched.

À lire ►

 

Meet Richard Budgell, Associate Professor of Inuit and Northern Health Promotion

Richard Budgell, newly appointed Associate Professor of Inuit and Northern Health Promotion in the Department of Family Medicine, has a background of more than 30 years as a public servant with the Government of Canada. “My primary motivation throughout my career has been working to enlarge the role and understanding of Indigenous people and to fight systemic discrimination,” says Richard, “In most parts of Canada – including Quebec – Indigenous people, communities and institutions are still not seen as full and rightful participants in the management of their own health and well-being.”
Read more ►

 

Laurent Duvernay-Tardif becomes first NFL player to opt out of 2020 season

Laurent Duvernay-Tardif, a key member of the Super Bowl champion Kansas City Chiefs, has opted out of the 2020 season – making him the first NFL player to announce that he won’t play in the upcoming season due to COVID-19 concerns.
Read more ►

 

Read More Posts From This Section »

Inappropriate prescriptions sending hospitalized seniors back to the ER

Two in three hospitalized seniors are prescribed drugs that should be avoided by older adults, increasing the risk of injury and adverse drug reactions. Improving hospital prescribing practices can reduce the frequency of inappropriate medications and resulting harm, according to a new study led by McGill University researchers.
Read more ►

 

Study identifies strategies to reduce breast cancer growth and related skeletal lesions

Bone metastasis is a major cause of morbidity and mortality in patients with breast cancer. However, current therapeutic approaches against breast cancer induced bone metastasis are mostly palliative and have minimal effect on cancer progression. In a recent paper published in Bone Research, a team of researchers led by Shafaat Rabbani, MD, at the Research Institute of the McGill University Health Centre has presented a novel approach to target both tumour growth and the skeletal lesions caused by breast cancer-induced bone disease.
Read more ►

 

New study offers first glimpse into how widespread COVID-19 antibodies are in Canada’s adult population

Today, Canadian Blood Services and Canada’s COVID-19 Immunity Task Force are releasing initial results of the first 10,000 blood donor samples assessed for SARS-CoV-2 antibodies. This analysis reveals that over the period May 9 through June 8, 2020, fewer than 1 per cent of the 10,000 samples from blood donors tested positive for antibodies to the novel coronavirus. Antibodies indicate past infection with SARS-CoV-2, and population studies like this one tell us how many people have likely been exposed to the virus.
Read more ►

 

Read More Posts From This Section »

2020 Maude Abbott, Haile. T. Debas and Rosemary Wedderburn Brown Prize winners announced

Each year, the McGill Faculty of Medicine and Health Sciences awards three prestigious prizes to deserving faculty members, which celebrate exceptional contributions to our tripartite mission of education, research and service to society, as well as the legacy of McGill luminaries who continue to inspire us today. We are pleased to announce the 2020 winners of the Maude Abbott, Haile. T. Debas and Rosemary Wedderburn Brown prizes.
Read more ►

 

Relève étoile Jacques-Genest June 2020

Marisa Cressatti, a PhD student in Neuroscience at McGill University, is the award winner of the Relève étoile Jacques-Genest award of the Fonds de recherche du Québec – Santé (FRQS). Congratulations Marisa!
Read more ►

 

Read More Posts From This Section »

Building a career in clinical and regulatory affairs

The first cohort of trainees from the Research Institute of the McGill University Health Centre will complete a novel training program in Clinical and Regulatory Affairs next month. Called the CRA Experience, the program is designed to help them develop the skills and expertise to transition into a variety of clinical and regulatory career paths in the life science sector.
Read more ►

 

Read More Posts From This Section »